img

Global Atazanavir Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Atazanavir Market Insights, Forecast to 2034

Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
Global Atazanavir market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Atazanavir industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Atazanavir key manufacturers include Bristol-Myers Squibb, TEVA, Cipla, Mylan, Aurobindo Pharma and Emcure, etc. Bristol-Myers Squibb, TEVA, Cipla are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Atazanavir were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Atazanavir market and estimated to attract more attentions from industry insiders and investors.
Atazanavir can be divided into 150 mg Capsule, 200 mg Capsule, 300 mg Capsule and 50 mg Oral Powder, etc. 150 mg Capsule is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Atazanavir is widely used in various fields, such as Adults and Children 3 months of age and older, etc. Adults provides greatest supports to the Atazanavir industry development. In 2022, global % sales of Atazanavir went into Adults filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Atazanavir market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Atazanavir market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure
Segment by Type
150 mg Capsule
200 mg Capsule
300 mg Capsule
50 mg Oral Powder

Segment by Application


Adults
Children 3 months of age and older

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Atazanavir plant distribution, commercial date of Atazanavir, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Atazanavir introduction, etc. Atazanavir Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Atazanavir
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Atazanavir Product Introduction
1.2 Market by Type
1.2.1 Global Atazanavir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 150 mg Capsule
1.2.3 200 mg Capsule
1.2.4 300 mg Capsule
1.2.5 50 mg Oral Powder
1.3 Market by Application
1.3.1 Global Atazanavir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children 3 months of age and older
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Atazanavir Sales Estimates and Forecasts 2018-2029
2.2 Global Atazanavir Revenue by Region
2.2.1 Global Atazanavir Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Atazanavir Revenue by Region (2018-2024)
2.2.3 Global Atazanavir Revenue by Region (2024-2029)
2.2.4 Global Atazanavir Revenue Market Share by Region (2018-2029)
2.3 Global Atazanavir Sales Estimates and Forecasts 2018-2029
2.4 Global Atazanavir Sales by Region
2.4.1 Global Atazanavir Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Atazanavir Sales by Region (2018-2024)
2.4.3 Global Atazanavir Sales by Region (2024-2029)
2.4.4 Global Atazanavir Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Atazanavir Sales by Manufacturers
3.1.1 Global Atazanavir Sales by Manufacturers (2018-2024)
3.1.2 Global Atazanavir Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atazanavir in 2022
3.2 Global Atazanavir Revenue by Manufacturers
3.2.1 Global Atazanavir Revenue by Manufacturers (2018-2024)
3.2.2 Global Atazanavir Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Atazanavir Revenue in 2022
3.3 Global Key Players of Atazanavir, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Atazanavir Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Atazanavir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Atazanavir, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Atazanavir, Product Offered and Application
3.8 Global Key Manufacturers of Atazanavir, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Atazanavir Sales by Type
4.1.1 Global Atazanavir Historical Sales by Type (2018-2024)
4.1.2 Global Atazanavir Forecasted Sales by Type (2024-2029)
4.1.3 Global Atazanavir Sales Market Share by Type (2018-2029)
4.2 Global Atazanavir Revenue by Type
4.2.1 Global Atazanavir Historical Revenue by Type (2018-2024)
4.2.2 Global Atazanavir Forecasted Revenue by Type (2024-2029)
4.2.3 Global Atazanavir Revenue Market Share by Type (2018-2029)
4.3 Global Atazanavir Price by Type
4.3.1 Global Atazanavir Price by Type (2018-2024)
4.3.2 Global Atazanavir Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Atazanavir Sales by Application
5.1.1 Global Atazanavir Historical Sales by Application (2018-2024)
5.1.2 Global Atazanavir Forecasted Sales by Application (2024-2029)
5.1.3 Global Atazanavir Sales Market Share by Application (2018-2029)
5.2 Global Atazanavir Revenue by Application
5.2.1 Global Atazanavir Historical Revenue by Application (2018-2024)
5.2.2 Global Atazanavir Forecasted Revenue by Application (2024-2029)
5.2.3 Global Atazanavir Revenue Market Share by Application (2018-2029)
5.3 Global Atazanavir Price by Application
5.3.1 Global Atazanavir Price by Application (2018-2024)
5.3.2 Global Atazanavir Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Atazanavir Market Size by Type
6.1.1 US & Canada Atazanavir Sales by Type (2018-2029)
6.1.2 US & Canada Atazanavir Revenue by Type (2018-2029)
6.2 US & Canada Atazanavir Market Size by Application
6.2.1 US & Canada Atazanavir Sales by Application (2018-2029)
6.2.2 US & Canada Atazanavir Revenue by Application (2018-2029)
6.3 US & Canada Atazanavir Market Size by Country
6.3.1 US & Canada Atazanavir Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Atazanavir Sales by Country (2018-2029)
6.3.3 US & Canada Atazanavir Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Atazanavir Market Size by Type
7.1.1 Europe Atazanavir Sales by Type (2018-2029)
7.1.2 Europe Atazanavir Revenue by Type (2018-2029)
7.2 Europe Atazanavir Market Size by Application
7.2.1 Europe Atazanavir Sales by Application (2018-2029)
7.2.2 Europe Atazanavir Revenue by Application (2018-2029)
7.3 Europe Atazanavir Market Size by Country
7.3.1 Europe Atazanavir Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Atazanavir Sales by Country (2018-2029)
7.3.3 Europe Atazanavir Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Atazanavir Market Size
8.1.1 China Atazanavir Sales (2018-2029)
8.1.2 China Atazanavir Revenue (2018-2029)
8.2 China Atazanavir Market Size by Application
8.2.1 China Atazanavir Sales by Application (2018-2029)
8.2.2 China Atazanavir Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Atazanavir Market Size by Type
9.1.1 Asia Atazanavir Sales by Type (2018-2029)
9.1.2 Asia Atazanavir Revenue by Type (2018-2029)
9.2 Asia Atazanavir Market Size by Application
9.2.1 Asia Atazanavir Sales by Application (2018-2029)
9.2.2 Asia Atazanavir Revenue by Application (2018-2029)
9.3 Asia Atazanavir Sales by Region
9.3.1 Asia Atazanavir Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Atazanavir Revenue by Region (2018-2029)
9.3.3 Asia Atazanavir Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Atazanavir Market Size by Type
10.1.1 Middle East, Africa and Latin America Atazanavir Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Atazanavir Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Atazanavir Market Size by Application
10.2.1 Middle East, Africa and Latin America Atazanavir Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Atazanavir Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Atazanavir Sales by Country
10.3.1 Middle East, Africa and Latin America Atazanavir Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Atazanavir Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Atazanavir Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Overview
11.1.3 Bristol-Myers Squibb Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bristol-Myers Squibb Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 TEVA
11.2.1 TEVA Company Information
11.2.2 TEVA Overview
11.2.3 TEVA Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 TEVA Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 TEVA Recent Developments
11.3 Cipla
11.3.1 Cipla Company Information
11.3.2 Cipla Overview
11.3.3 Cipla Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Cipla Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cipla Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aurobindo Pharma Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 Emcure
11.6.1 Emcure Company Information
11.6.2 Emcure Overview
11.6.3 Emcure Atazanavir Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Emcure Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emcure Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Atazanavir Industry Chain Analysis
12.2 Atazanavir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Atazanavir Production Mode & Process
12.4 Atazanavir Sales and Marketing
12.4.1 Atazanavir Sales Channels
12.4.2 Atazanavir Distributors
12.5 Atazanavir Customers
13 Market Dynamics
13.1 Atazanavir Industry Trends
13.2 Atazanavir Market Drivers
13.3 Atazanavir Market Challenges
13.4 Atazanavir Market Restraints
14 Key Findings in The Global Atazanavir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Atazanavir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 150 mg Capsule
Table 3. Major Manufacturers of 200 mg Capsule
Table 4. Major Manufacturers of 300 mg Capsule
Table 5. Major Manufacturers of 50 mg Oral Powder
Table 6. Global Atazanavir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Atazanavir Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Atazanavir Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Atazanavir Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Atazanavir Revenue Market Share by Region (2018-2024)
Table 11. Global Atazanavir Revenue Market Share by Region (2024-2029)
Table 12. Global Atazanavir Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Atazanavir Sales by Region (2018-2024) & (K Units)
Table 14. Global Atazanavir Sales by Region (2024-2029) & (K Units)
Table 15. Global Atazanavir Sales Market Share by Region (2018-2024)
Table 16. Global Atazanavir Sales Market Share by Region (2024-2029)
Table 17. Global Atazanavir Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Atazanavir Sales Share by Manufacturers (2018-2024)
Table 19. Global Atazanavir Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Atazanavir Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Atazanavir, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Atazanavir Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Atazanavir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Atazanavir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atazanavir as of 2022)
Table 25. Global Key Manufacturers of Atazanavir, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Atazanavir, Product Offered and Application
Table 27. Global Key Manufacturers of Atazanavir, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Atazanavir Sales by Type (2018-2024) & (K Units)
Table 30. Global Atazanavir Sales by Type (2024-2029) & (K Units)
Table 31. Global Atazanavir Sales Share by Type (2018-2024)
Table 32. Global Atazanavir Sales Share by Type (2024-2029)
Table 33. Global Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Atazanavir Revenue Share by Type (2018-2024)
Table 36. Global Atazanavir Revenue Share by Type (2024-2029)
Table 37. Atazanavir Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Atazanavir Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Atazanavir Sales by Application (2018-2024) & (K Units)
Table 40. Global Atazanavir Sales by Application (2024-2029) & (K Units)
Table 41. Global Atazanavir Sales Share by Application (2018-2024)
Table 42. Global Atazanavir Sales Share by Application (2024-2029)
Table 43. Global Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Atazanavir Revenue Share by Application (2018-2024)
Table 46. Global Atazanavir Revenue Share by Application (2024-2029)
Table 47. Atazanavir Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Atazanavir Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Atazanavir Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Atazanavir Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Atazanavir Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Atazanavir Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Atazanavir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Atazanavir Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Atazanavir Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Atazanavir Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Atazanavir Sales by Country (2024-2029) & (K Units)
Table 62. Europe Atazanavir Sales by Type (2018-2024) & (K Units)
Table 63. Europe Atazanavir Sales by Type (2024-2029) & (K Units)
Table 64. Europe Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Atazanavir Sales by Application (2018-2024) & (K Units)
Table 67. Europe Atazanavir Sales by Application (2024-2029) & (K Units)
Table 68. Europe Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Atazanavir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Atazanavir Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Atazanavir Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Atazanavir Sales by Country (2018-2024) & (K Units)
Table 74. Europe Atazanavir Sales by Country (2024-2029) & (K Units)
Table 75. China Atazanavir Sales by Type (2018-2024) & (K Units)
Table 76. China Atazanavir Sales by Type (2024-2029) & (K Units)
Table 77. China Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Atazanavir Sales by Application (2018-2024) & (K Units)
Table 80. China Atazanavir Sales by Application (2024-2029) & (K Units)
Table 81. China Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Atazanavir Sales by Type (2018-2024) & (K Units)
Table 84. Asia Atazanavir Sales by Type (2024-2029) & (K Units)
Table 85. Asia Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Atazanavir Sales by Application (2018-2024) & (K Units)
Table 88. Asia Atazanavir Sales by Application (2024-2029) & (K Units)
Table 89. Asia Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Atazanavir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Atazanavir Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Atazanavir Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Atazanavir Sales by Region (2018-2024) & (K Units)
Table 95. Asia Atazanavir Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Atazanavir Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Atazanavir Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Atazanavir Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Atazanavir Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Atazanavir Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Atazanavir Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Atazanavir Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Atazanavir Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Atazanavir Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Atazanavir Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Atazanavir Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Atazanavir Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Atazanavir Sales by Country (2024-2029) & (K Units)
Table 109. Bristol-Myers Squibb Company Information
Table 110. Bristol-Myers Squibb Description and Major Businesses
Table 111. Bristol-Myers Squibb Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Bristol-Myers Squibb Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. TEVA Company Information
Table 115. TEVA Description and Major Businesses
Table 116. TEVA Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. TEVA Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. TEVA Recent Developments
Table 119. Cipla Company Information
Table 120. Cipla Description and Major Businesses
Table 121. Cipla Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Cipla Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Cipla Recent Developments
Table 124. Mylan Company Information
Table 125. Mylan Description and Major Businesses
Table 126. Mylan Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Mylan Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Mylan Recent Developments
Table 129. Aurobindo Pharma Company Information
Table 130. Aurobindo Pharma Description and Major Businesses
Table 131. Aurobindo Pharma Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Aurobindo Pharma Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Aurobindo Pharma Recent Developments
Table 134. Emcure Company Information
Table 135. Emcure Description and Major Businesses
Table 136. Emcure Atazanavir Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Emcure Atazanavir Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Emcure Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Atazanavir Distributors List
Table 142. Atazanavir Customers List
Table 143. Atazanavir Market Trends
Table 144. Atazanavir Market Drivers
Table 145. Atazanavir Market Challenges
Table 146. Atazanavir Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Atazanavir Product Picture
Figure 2. Global Atazanavir Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Atazanavir Market Share by Type in 2022 & 2029
Figure 4. 150 mg Capsule Product Picture
Figure 5. 200 mg Capsule Product Picture
Figure 6. 300 mg Capsule Product Picture
Figure 7. 50 mg Oral Powder Product Picture
Figure 8. Global Atazanavir Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Atazanavir Market Share by Application in 2022 & 2029
Figure 10. Adults
Figure 11. Children 3 months of age and older
Figure 12. Atazanavir Report Years Considered
Figure 13. Global Atazanavir Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Atazanavir Revenue 2018-2029 (US$ Million)
Figure 15. Global Atazanavir Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Atazanavir Revenue Market Share by Region (2018-2029)
Figure 17. Global Atazanavir Sales 2018-2029 ((K Units)
Figure 18. Global Atazanavir Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Atazanavir Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Atazanavir Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Atazanavir Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Atazanavir Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Atazanavir Sales YoY (2018-2029) & (K Units)
Figure 24. China Atazanavir Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Atazanavir Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Atazanavir Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Atazanavir Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Atazanavir Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Atazanavir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Atazanavir in the World: Market Share by Atazanavir Revenue in 2022
Figure 31. Global Atazanavir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Atazanavir Sales Market Share by Type (2018-2029)
Figure 33. Global Atazanavir Revenue Market Share by Type (2018-2029)
Figure 34. Global Atazanavir Sales Market Share by Application (2018-2029)
Figure 35. Global Atazanavir Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Atazanavir Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Atazanavir Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Atazanavir Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Atazanavir Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Atazanavir Revenue Share by Country (2018-2029)
Figure 41. US & Canada Atazanavir Sales Share by Country (2018-2029)
Figure 42. U.S. Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Atazanavir Sales Market Share by Type (2018-2029)
Figure 45. Europe Atazanavir Revenue Market Share by Type (2018-2029)
Figure 46. Europe Atazanavir Sales Market Share by Application (2018-2029)
Figure 47. Europe Atazanavir Revenue Market Share by Application (2018-2029)
Figure 48. Europe Atazanavir Revenue Share by Country (2018-2029)
Figure 49. Europe Atazanavir Sales Share by Country (2018-2029)
Figure 50. Germany Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 51. France Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 55. China Atazanavir Sales Market Share by Type (2018-2029)
Figure 56. China Atazanavir Revenue Market Share by Type (2018-2029)
Figure 57. China Atazanavir Sales Market Share by Application (2018-2029)
Figure 58. China Atazanavir Revenue Market Share by Application (2018-2029)
Figure 59. Asia Atazanavir Sales Market Share by Type (2018-2029)
Figure 60. Asia Atazanavir Revenue Market Share by Type (2018-2029)
Figure 61. Asia Atazanavir Sales Market Share by Application (2018-2029)
Figure 62. Asia Atazanavir Revenue Market Share by Application (2018-2029)
Figure 63. Asia Atazanavir Revenue Share by Region (2018-2029)
Figure 64. Asia Atazanavir Sales Share by Region (2018-2029)
Figure 65. Japan Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 69. India Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Atazanavir Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Atazanavir Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Atazanavir Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Atazanavir Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Atazanavir Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Atazanavir Sales Share by Country (2018-2029)
Figure 76. Brazil Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Atazanavir Revenue (2018-2029) & (US$ Million)
Figure 81. Atazanavir Value Chain
Figure 82. Atazanavir Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries